PAEP
PAEP (progestagen associated endometrial protein) encodes glycodelin, a secreted lipocalin glycoprotein that regulates key steps in fertilisation and has immunomodulatory effects. It is also known as PP14, PEP, PAEG and GD, and was formerly called placental protein 14. Browse Assay Genie's current range of PAEP research reagents below, or read on for the biology behind the target.
PAEP is a glycoprotein that regulates critical steps during fertilisation and also has immunomodulatory effects. Four glycoforms, glycodelin-S, -A, -F and -C, have been identified in reproductive tissues, and they differ in glycosylation and biological activity. Glycodelin-A has contraceptive and immunosuppressive activities. Glycodelin-C stimulates the binding of spermatozoa to the zona pellucida, whereas glycodelin-F inhibits that binding and significantly suppresses the progesterone-induced acrosome reaction. Glycodelin-S in seminal plasma maintains the uncapacitated state of human spermatozoa.
The PAEP gene belongs to the kernel lipocalin superfamily. Members of this group share relatively low sequence similarity but have a highly conserved exon/intron structure and three-dimensional fold, and most lipocalins are clustered on the long arm of chromosome 9. The protein is a member of the calycin superfamily and the lipocalin family, and the HGNC places it in the lipocalins gene group. The product is secreted. Alternative splicing results in multiple transcript variants.
According to the NCBI Gene summary, forms with identical protein backbones but different glycosylation profiles are found in amniotic fluid, follicular fluid and seminal plasma. These forms have distinct and essential roles in establishing a uterine environment suitable for pregnancy, and in the timing and sequence of events during fertilisation. The protein has been called pregnancy-associated endometrial alpha-2-globulin, placental protein 14 and glycodelin, before the official name progestagen-associated endometrial protein was adopted.
Glycodelin glycoforms regulate sperm binding to the zona pellucida and the acrosome reaction, making PAEP relevant to studies of fertilisation.
Glycodelin-A has immunosuppressive activity, so PAEP is studied in immunomodulation within the reproductive system.
PAEP-encoded glycoproteins help establish a uterine environment suitable for pregnancy and the correct sequence of early reproductive events.
Identical protein backbones with different glycosylation give distinct activities, which makes PAEP a useful model within the lipocalin family.
PAEP encodes glycodelin, a secreted glycoprotein that regulates critical steps in fertilisation and has immunomodulatory effects. Its glycoforms differ in activity: glycodelin-A is contraceptive and immunosuppressive, glycodelin-C promotes sperm binding to the zona pellucida, and glycodelin-F inhibits it.
PAEP is also known as glycodelin, PP14, PEP, PAEG, GD, GdA, GdS and GdF. Earlier names include placental protein 14, pregnancy-associated endometrial alpha-2-globulin and progestagen-associated endometrial protein. Alternative splicing gives multiple transcript variants, and distinct glycoforms share one protein backbone.
PAEP belongs to the lipocalin family within the calycin superfamily. Lipocalins share relatively low sequence similarity but have conserved exon/intron structure and three-dimensional folding, and most are clustered on the long arm of chromosome 9. Check the datasheet of any product for its validated reactivity.
Other lipocalin family members and related reproductive biology targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P09466; product specifications from Assay Genie datasheets.